about
Pharmacological treatment of depression in patients with a primary brain tumourPharmacological treatment of depression in patients with a primary brain tumourThe role of lamotrigine in the management of bipolar disorderThe pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjectsUpdate on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.Antiepileptic drug interactions - principles and clinical implications.Psychiatric treatment considerations with direct acting antivirals in hepatitis CValproic Acid-induced Hyperammonemic Encephalopathy Promoted by LevetiracetamClinically significant psychotropic drug-drug interactions in the primary care setting.Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary careClinically relevant drug interactions with antiepileptic drugsTherapeutic drug monitoring of old and newer anti-epileptic drugs.Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra-high-performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring.Bipolar disorder in women: reproductive events and treatment considerations.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments.Induction of neuronal differentiation of rat muscle-derived stem cells in vitro using basic fibroblast growth factor and ethosuximide.Safe Treatment of Seizures in the Setting of HIV/AIDS.The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action.Drug interactions involving the new second- and third-generation antiepileptic drugs.Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease.Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.Lamotrigine-induced neutropenia following two attempts to increase dosage above 50 mg/day with recovery between episodes.Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy
P2860
Q24202721-4A73C879-D625-4AF1-A7BA-AC96132608BEQ24236728-19D80337-0647-48C6-BFD9-D6853B519FBEQ24658110-F86BE8F6-CFA7-47F1-9384-F44582767431Q24678717-FC188F1E-5545-4C3F-B9DA-B965EB69D31FQ33664128-4DFEA3C1-DB15-467A-86A4-5D51D6027796Q34402188-0F907956-7B43-45BA-B742-821B37D9BD68Q34721628-7A527090-812E-447D-8E85-20EBE0E0D6D9Q34965419-C461A4BD-BD51-4170-A67F-2DB9C28DC169Q35104220-C05B13FD-E32A-441F-B58A-2A2533F532BCQ35827051-ACFDCD2A-458A-4E92-8727-B4E7B0CEA09BQ35827491-10D7A25A-9394-48CC-8E3D-C71917AF5BB3Q35970354-B71AB386-5C36-47A2-A3B7-05F57E9FD8A6Q36078224-274E9857-53DF-49F7-8058-6AE4027776E5Q36181505-66E74D99-25B3-4B06-983C-C59A208B84CEQ36199036-33FFF1ED-1AD6-42D4-B3B7-27977D3D73D2Q36662893-E6AA3CC7-B940-44E3-A025-6F52C53B4E5BQ36820354-DF465DF8-166B-48F4-97E4-3BD3C38704C0Q37096562-9080DC04-21B0-465D-82EF-8EB864D56042Q37610170-C9973761-5DB9-488A-A0A1-C300ECB0DDBBQ37658910-8FD333F0-EF92-436A-B759-5D6775F12759Q38115721-7CAE681A-D6CF-42ED-833A-C3B2EFE3EBFCQ38451960-04F7D6AB-4B10-4603-AFDC-263FFE385816Q43918721-B388D5FD-97D0-4495-9CFF-8172D974F873Q44152059-28B9B53E-5FE6-4D0D-80E9-41A76AC22C6DQ45117148-0081EE01-4779-4250-A574-CEDAB1B24617Q46984881-E8062FF0-585E-4647-B276-318201D83001Q57770173-D20CB727-805B-403D-B40A-74F090B61AE9
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New antiepileptic drugs: review on drug interactions.
@ast
New antiepileptic drugs: review on drug interactions.
@en
New antiepileptic drugs: review on drug interactions.
@nl
type
label
New antiepileptic drugs: review on drug interactions.
@ast
New antiepileptic drugs: review on drug interactions.
@en
New antiepileptic drugs: review on drug interactions.
@nl
prefLabel
New antiepileptic drugs: review on drug interactions.
@ast
New antiepileptic drugs: review on drug interactions.
@en
New antiepileptic drugs: review on drug interactions.
@nl
P2093
P1476
New antiepileptic drugs: review on drug interactions.
@en
P2093
Houda Hachad
Isabelle Ragueneau-Majlessi
Rene H Levy
P304
P356
10.1097/00007691-200202000-00016
P577
2002-02-01T00:00:00Z